Generic Opioid Drug Manufacturer Agrees To $272.5M Multistate Settlement
NEW YORK — The New York attorney general on May 3 announced that generic opioid manufacturer Amneal Pharmaceuticals has agreed to a multistate settlement for its role in the nationwide opioid...To view the full article, register now.
Already a subscriber? Click here to view full article